Early research (Phase 1)Study completedNCT01144936What this trial is testingStudy of VX-985 in Subjects With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Vertex Pharmaceuticals Incorporated 21
Large-scale testing (Phase 3)WithdrawnNCT02806362What this trial is testingStudy of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)Who this might be right forChronic Hepatitis C Virus AbbVie
Large-scale testing (Phase 3)Study completedNCT02473211What this trial is testingSOF Plus DCV in Treating Chinese Treatment-experienced HCV PatientsWho this might be right forChronic Hepatitis C Infection Humanity and Health Research Centre 106
Testing effectiveness (Phase 2)Study completedNCT02716428What this trial is testingFaldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus InfectionWho this might be right forHepatitis C Viral InfectionChronic Hepatitis CHepatitis C (HCV)+1 more Trek Therapeutics, PBC 25
Testing effectiveness (Phase 2)WithdrawnNCT02397395What this trial is testingAn Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.Who this might be right forRenal ImpairmentEnd-stage Renal Disease Janssen R&D Ireland
Large-scale testing (Phase 3)Study completedNCT02219503What this trial is testingEvaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and CirrhosisWho this might be right forChronic Hepatitis C InfectionCompensated Cirrhosis AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT01194037What this trial is testingA Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CWho this might be right forChronic Hepatitis C InfectionGenotype 1 HanAll BioPharma Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00621296What this trial is testingSafety and Efficacy of MP-424 to Treat Chronic Hepatitis CWho this might be right forHepatitis C Tanabe Pharma Corporation 15
Early research (Phase 1)Study completedNCT00591214What this trial is testingSafety and PK Study of MP-424 to Treat Chronic Hepatitis CWho this might be right forChronic Hepatitis C Tanabe Pharma Corporation 10
Early research (Phase 1)Study completedNCT01247194What this trial is testingA Phase 1b Study of PPI-461 in Patients With HCV Genotype 1Who this might be right forChronic Genotype 1 Hepatitis C Virus Infection Presidio Pharmaceuticals, Inc. 24
Not applicableUnknownNCT02865369What this trial is testingRegression of Liver Fibrosis After Daclatasvir and Asunaprevir TreatmentWho this might be right forChronic Hepatitis C Sang Gyune Kim 103
Testing effectiveness (Phase 2)Study completedNCT03485846What this trial is testingEfficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bWho this might be right forChronic Hepatitis C Genotype 1b R-Pharm 105
Post-approval studies (Phase 4)Ended earlyNCT03723824What this trial is testingGrazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney TransplantationWho this might be right forChronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection Taichung Veterans General Hospital 14
Early research (Phase 1)Study completedNCT01700179What this trial is testingEvaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b ParticipantsWho this might be right forChronic Hepatitis C Infection Alexion Pharmaceuticals, Inc. 8
Post-approval studies (Phase 4)Study completedNCT02580474What this trial is testingThe Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal FailureWho this might be right forHepatitis C Myeong Jun Song 21
Large-scale testing (Phase 3)Study completedNCT02023099What this trial is testingStudy to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) InfectionWho this might be right forChronic Hepatitis C Infection AbbVie 363
Post-approval studies (Phase 4)Study completedNCT03050905What this trial is testingProof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1BWho this might be right forHCV Coinfection HaEmek Medical Center, Israel 7
Large-scale testing (Phase 3)Study completedNCT02973503What this trial is testingStudy to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe FibrosisWho this might be right forChronic HCV Infection University Hospital, Clermont-Ferrand 117
Not applicableStudy completedNCT03053180What this trial is testingReal World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian FederationWho this might be right forChronic Hepatitis C AbbVie 60
Post-approval studies (Phase 4)Study completedNCT00245414What this trial is testingTrial of Pegasys® in Patients With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Chugai Pharmaceutical 108